Augustin Boudry

9PUBLICATIONS

50CO-AUTHORS

Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Liquid biopsiesMedical mycology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jun 23, 2026

Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

|May 28, 2026

Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort.

|May 21, 2026

Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

|May 12, 2026

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

|Sep 03, 2025

Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia.

Augustin Boudry, Laure Goursaud, Delphine Lebon

|Oct 17, 2024

Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia.

Romane Joudinaud, Augustin Boudry, Laurène Fenwarth

Pageof 2

Frequent Collaborators

Nicolas Duployez

Laurene Fenwarth

Raphaël Itzykson

Christian Récher

Jean-Baptiste Micol

Eric Delabesse

Sarah Bertoli

Mathilde Hunault

Pierre-Yves Dumas

Emmanuelle Tavernier

Frequent Collaborators

Nicolas Duployez

Laurene Fenwarth

Raphaël Itzykson

Christian Récher